Relay Therapeutics, Inc. RLAY Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$73.29M-33.5% | -$54.89M+26.0% | -$74.15M-5.4% | -$70.38M+8.7% | -$77.07M-1.4% | ||
| $504K-15.9% | $599K-19.9% | $748K-25.3% | $1M-17.1% | $1.21M-9.4% | ||
| $10.54M-19.4% | $13.07M-15.8% | $15.53M+7.1% | $14.5M-25.0% | $19.33M+9.6% | ||
| $3.67M+156% | -$6.53M-1,189% | -$507K+46.8% | -$953K+72.3% | -$3.45M-131% | ||
| $384K+162% | -$615K— | —— | -$1.07M-248% | -$308K-149% | ||
| —— | —— | —— | —— | -$7.68M-500% | ||
| -$7.36M-92.7% | -$3.82M-196% | $3.97M+170% | -$5.69M-245% | $3.93M— | ||
| -$51.11M-13.9% | -$44.87M+27.8% | -$62.12M-12.4% | -$55.26M+24.5% | -$73.21M-26.5% | ||
| —— | $1K— | $0-100% | $26K-93.2% | $384K— | ||
| $50.9M+49.7% | $34M-41.5% | $58.08M+550% | $8.93M-59.4% | $21.97M-70.7% | ||
| $83.8M+20.6% | $69.46M-29.0% | $97.8M+16.3% | $84.1M+29.7% | $64.82M-37.7% | ||
| $32.9M-7.2% | $35.46M-10.7% | $39.73M-47.1% | $75.15M+77.0% | $42.47M— | ||
| $138.78M+14,759% | $934K+5,394% | $17K— | —— | —— | ||
| $120.57M+1,524% | -$8.47M+62.2% | -$22.38M— | —— | -$30.75M-9.5% | ||
| $782K-8.8% | $857K-22.2% | $1.1M-21.0% | $1.39M-12.7% | $1.6M-26.8% | ||
| $504K-15.9% | $599K-19.9% | $748K-25.3% | $1M-17.1% | $1.21M-9.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | -$7.68M-500% | ||
| -$506K— | —— | —— | $5.57M+2,068% | -$283K-0.4% | ||
| -$7.36M-92.7% | -$3.82M-196% | $3.97M+170% | -$5.69M-245% | $3.93M— | ||
| $1.69M— | —— | $17K— | —— | —— | ||
| $137.09M— | —— | —— | —— | —— | ||
| —— | $1.73M0.0% | $1.73M0.0% | $1.73M0.0% | $1.73M— | ||
| —— | —— | —— | -$96K-257% | $61K— | ||
| $0— | —— | —— | —— | -$2.51M-500% | ||
| —— | -$44.87M+27.8% | -$62.12M-12.4% | -$55.29M+24.9% | -$73.59M-27.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Relay Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Relay Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.